Zdrowie i gospodarka · 08/02/2023

FDA Denies Dr. Hassan Tahsildar's Request for Hearing, Imposes 2-Year Debarment

The FDA has denied Dr. Hassan Tahsildar's request for a hearing and imposed a 2-year debarment from providing services related to approved or pending drug product applications, following his conviction for introducing misbranded drugs into interstate commerce.